McPeake, Joanne
Kentish-Barnes, Nancy
Banse, Emilie
Anderson, Lynne
Cuzco, Cecilia
Azoulay, Elie
Quasim, Tara
Castro, Pedro
Puxty, Kathryn
Funding for this research was provided by:
THIS Institute, University of Cambridge (PD-2019-02-16)
European Society of Intensive Care Medicine
Article History
Received: 31 October 2022
Accepted: 11 January 2023
First Online: 21 January 2023
Declarations
:
: UK: This study was approved by the Scientific Officer of the West of Scotland Research Ethics Service as Service Evaluation (UK approval); the Hospital Clínic of Barcelona Medical Research Ethics Committee (HCB/2021/1115) (Spain approval); and the research ethics board Sud Méditerranée (2020-A00809-30; CNRIPH: 20.03.27.73019) within the framework of the BURDENCOV study (France approval).
: JM is funded via a Fellowship from The Healthcare Improvement Studies Institute (University of Cambridge (PD-2019-02-16). Dr Azoulay reported receipt of personal fees (lectures) from Pfizer, Gilead, Baxter, and Alexion; and institutional research grants from Merck Sharp and Dohme, Pfizer, Baxter, and Alexion outside the submitted work